fredag 1 september 2023

Viktig forskningsrapport från USA

Oscar mejlade över en ny studie där resultaten kommer ha stor betydelse för framtida bröstcancerforskning samt vid framtagning av nya läkemedel mot denna best. 

Comparative Morphological Analysis of MCF10A and MCF7 Cells Using Holographic Time-lapse Microscopy

Studien har såpass bra impact att statliga NIH var snabba att lägga upp den i sitt bibliotek.


Comparative Morphological Analysis of MCF10A and MCF7 Cells Using Holographic Time-lapse Microscopy

Värt att notera i sammanhanget är att bägge sajterna lyfter fram HoloMonitor som Key Words.
Först hos ursprungsstället studien publicerades på, ANTICANCER RESEARCH

Sen hos NIH. 

Bra signal till andra forskare och naturligtvis bra reklam för PHI.

Men till studien och dess abstract där jag tar mig friheten att använda mig av NIH`s beskrivning.
Ni förstår säkert varför när ni jämför sidorna.(om inte kolla mina fetningar)
Abstract

Background/aimBreast cancer, one of the most prevalent cancers globally, is marked by its cellular heterogeneity. A key aspect of breast cancer research is understanding the distinct morphological features of cancerous and non-cancerous cells, which could serve as potential targets for novel therapeutic interventions. In this light, our study aimed to comprehensively analyze the morphological features of the MCF10A and MCF7 cell lines, representing normal breast and breast cancer cells, respectively. The ultimate objective was to identify the most significant features that differentiate these cell lines.

Materials and methodsWe utilized advanced imaging techniques such as holographic time-lapse microscopy, which provides real-time, three-dimensional imaging of cells, to conduct our comparative analysis. This allowed us to examine dynamic cellular morphology and behavior with exceptional sensitivity and resolution over time. 
The primary features assessed in our study included texture clustershade, area (μm2), eccentricity, irregularity, phaseshift sum, optical volume (μm3), shape convexity, and Hull convexity.

ConclusionThe identified morphological differences between MCF10A and MCF7 cells offer valuable insights into the characteristics distinguishing normal breast cells from breast cancer cells. These findings not only contribute to our understanding of the morphological variability in breast cancer but also underscore the potential utility of these differences in future cancer diagnostics and treatment strategies.

Materials and Methods (urval)

Cell culture
MCF10A cells were seeded in the 24-well plates 24 h before cells were visualized under a holomonitor. MCF10A cells were maintained in MEBM Basal Medium supplemented with BPE, hEGF, Insulin, hydrocortisone, GA-1000 (Lonza, Basel, Switzerland). MCF7 cells were maintained in DMEM medium (Gibco, New York City, NY, USA), 10% FBS (HyClone, Logan, UT, USA), 5% Penicillin/Streptomycin, Insulin (1 mg/ml, Gibco) at 37°C with 5% CO2.

Quantitative phase imaging
The digital holographic monitor investigations were carried out with a HoloMonitor M4, produced by Phase Holographic Imaging (PHI, Lund, Sweden), which was placed inside the mammalian cell culture incubator at 37°C with a 5% CO2 environment. Time-lapse phase imaging, alongside image processing, segmentation, and analysis were performed via the Hstudio software package provided by PHI. The proliferation of cells was evaluated by imaging every 15 min following 24 h after plating. In each well, the images were segmented, identified and cells were counted using the Cell Count module in HStudio software. For the tracking assays mentioned standard culture conditions were followed and cells were plated in 24-well plates (Sarstedt, Hildesheim, Germany).


Results
In this study, we conducted a comprehensive analysis of morphological feature changes between MCF10A, a normal breast cell line, and MCF7, a breast cancer cell line (Figure 1). In our analysis of the breast cancer dataset, we aimed to identify the morphological features that most significantly differentiate between MCF10A and MCF7 cell lines. To achieve this, we employed a feature selection technique based on mutual information, followed by t-tests to assess the statistical significance of the differences observed. We also generated boxplots, violin plots, and density plots for each of the top 10 features to visually inspect the distributions of these features for the two cell lines.

Figure 1.

Digital Holographic images of the (A). MCF10A and (B). MCF7 pseudo colored using HStudio.

Bilden ovan visar alltså hur HoloMonitor särskiljer friska celler (vänster bild) från cancerceller.

Figure 2.

Box plots and violin plots of the texture clustershade, area, eccentricity, irregularity, optical volume, and phaseshift sum. Images were taken with the PHI digital phase imaging microscope (PHI, Lund, Sweden). Images were processed and analyzed using Hstudio. A, B: Violin and box plots of texture clustershade; C, D: Violin and box plots of area; E, F: Violin and box plots of eccentricity; G, H: Violin and box plots of irregularity; I, J: Violin and box plots of Otical volume; K, L: phaseshift sum.

Figure 3.

Box plots and violin plots of the shape and hull convexity. Images were taken with the PHI digital phase imaging microscope (PHI, Lund, Sweden). Images were processed and analyzed using Hstudio. A, B: Violin and box plots of shape convexity; C, D: Violin and box plots of Hull convexity.


Min kommentar
Jag får återigen upprepa mig likt en papegoja : HoloMonitor är en cancerforskares kanske bästa vän.
Iochmed denna studie kommer världens bröstcancerforskare ha ett annat utgångsläge när de gör sina studier. Även läkemedelstillverkarna kommer gå till denna studie för att göra förbättringar i sina produkter riktade till bröstcancerpatienter. I skenet av studiens betydelse är det förståeligt att NIH var snabba att uppmärksamma den. Man förstår även varför NIH och Anticancer Research har valt att ta med HoloMonitor som nyckelord.
Nu hoppas jag att PHI är smarta och använder denna studie i sin marknadsföring till cancerforskarna.
PR-värdet är massivt tack vare både studiens upptäckt som vilken "highlight" HoloMonitor får i presentationen.

Ett bra tillfälle att visa upp studien kanske infaller under nästa veckas utställning i England?

                                            Mvh the99
Tillägg
En uppmärksam phi,are är snabb att mejla över en ny studie om prostatacancer jag tydligen missat.
Ni får själva läsa om hur forskarna använt sig av HoloMonitor och vad de kom fram till.


Som service till alla ev HoloMonitornyfikna forskare : HoloMonitor Demo

Inga kommentarer:

Skicka en kommentar